<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Biotechnology / Drugs / Pharmaceuticals policy / Pharmacy / Biosimilar / Biopharmaceutical / Generic drug / Pharmaceutical drug / Orphan drug
Date: 2015-09-23 06:22:13
Pharmaceutical industry
Biotechnology
Drugs
Pharmaceuticals policy
Pharmacy
Biosimilar
Biopharmaceutical
Generic drug
Pharmaceutical drug
Orphan drug

Intellectual Property Listings NAME FIRM LOCATION

Add to Reading List

Source URL: www.managingip.com

Download Document from Source Website

File Size: 380,87 KB

Share Document on Facebook

Similar Documents

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v8Wa - View Document

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

DocID: 1v7ko - View Document

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v72B - View Document

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

DocID: 1v5W2 - View Document

TERMINOLOGY What is a Biopharmaceutical?

DocID: 1v5mX - View Document